Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma-Reference-Cited by-同舟云学术

Metastasis-specific patterns of response and progression with anti-PD-1 treatment in metastatic melanoma

Published:2017-12-07 Issue:3 Volume:31 Page:404-410
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Lee Jenny H. J.¹²³^ORCID,Lyle Megan²⁴⁵,Menzies Alexander M.²⁴⁶,Chan Matthew M. K.⁷,Lo Serigne²⁴,Clements Arthur⁸⁹,Carlino Matteo S.²³⁴,Kefford Richard F.¹²³⁴,Long Georgina V.²⁴⁶

Affiliation:

1. Departments of Biomedical Sciences and Clinical Medicine; Macquarie University; Sydney NSW Australia

2. Melanoma Institute Australia; Sydney NSW Australia

3. Crown Princess Mary Cancer Centre; Westmead Hospital; Sydney NSW Australia

4. University of Sydney; Sydney NSW Australia

5. Liz Plummer Cancer Care Centre; Cairns Hospital; Cairns QLD Australia

6. Royal North Shore Hospital; Sydney NSW Australia

7. Gosford Hospital; Gosford NSW Australia

8. Norwest hospital; Sydney NSW Australia

9. Sydney Adventist Hospital; Sydney NSW Australia

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12675/fullpdf

Reference24 articles.

1. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma;Frederick;Clinical Cancer Research,2013

2. Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient;Gonen;Radiology,2001

3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;New England Journal of Medicine,2013

4. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;New England Journal of Medicine,2010

5. Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature;Kamposioras;Critical Reviews in Oncology Hematology,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response and outcome of patients with melanoma skin metastases and immune checkpoint inhibition;International Journal of Cancer;2024-07-20

2. Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy;Cancers;2024-06-04

3. Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer;Oral Oncology;2024-05

4. Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma;2024-04-27

5. Single-cell RNA sequencing in melanoma: what have we learned so far?;eBioMedicine;2024-02